BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28771526)

  • 1. An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.
    Zhang Y; Su X; Kong Z; Fu F; Zhang P; Wang D; Wu H; Wan X; Li Y
    PLoS One; 2017; 12(8):e0182305. PubMed ID: 28771526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation.
    Hu J; Deng J; Cao R; Xiong S; Guo J
    Mol Cell Probes; 2020 Oct; 53():101607. PubMed ID: 32470500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
    Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
    Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins.
    Li L; Li X; The E; Wang LJ; Yuan TY; Wang SY; Feng J; Wang J; Liu Y; Wu YH; Ma XE; Ge J; Cui YY; Jiang XY
    PLoS One; 2015; 10(3):e0120550. PubMed ID: 25806802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
    Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
    Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells.
    Lv S; Pu X; Luo M; Wen H; Xu Z; Wei Q; Dang Q
    Prostate; 2021 Sep; 81(12):893-901. PubMed ID: 34184786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells.
    Dai X; Liu L; Liang Z; Guo K; Xu S; Wang H
    Pathol Res Pract; 2019 Apr; 215(4):712-721. PubMed ID: 30642743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA GAS5 modulates α-Solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells.
    Yang J; Hao T; Sun J; Wei P; Zhang H
    Biomed Pharmacother; 2019 Apr; 112():108656. PubMed ID: 30970507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.
    Yacqub-Usman K; Pickard MR; Williams GT
    Prostate; 2015 May; 75(7):693-705. PubMed ID: 25650269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines.
    Pickard MR; Mourtada-Maarabouni M; Williams GT
    Biochim Biophys Acta; 2013 Oct; 1832(10):1613-23. PubMed ID: 23676682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
    Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
    Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.
    Zhang P; Lu Y; Kong Z; Zhang Y; Fu F; Su X; Huang Y; Wan X; Li Y
    Prostate; 2019 Jun; 79(9):994-1006. PubMed ID: 31012142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.
    Liu Y; Zhao J; Zhang W; Gan J; Hu C; Huang G; Zhang Y
    Sci Rep; 2015 May; 5():10159. PubMed ID: 25959498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
    Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA GAS5 regulates vascular smooth muscle cell cycle arrest and apoptosis via p53 pathway.
    Tang R; Mei X; Wang YC; Cui XB; Zhang G; Li W; Chen SY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2516-2525. PubMed ID: 31167125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.